KJ015

· Shanghai Bao Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KJ015, covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors [Phase 1]